EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

To use or not use lisdexamfetamine in pregnancy and breastfeeding: a case report highlighting ADHD management and maternal–fetal outcomes

Tammy H Tran iD, Marissa L Beal iD, Melissa F Free, Ritika Baweja iD

Therapeutic Advances in Reproductive Health · 2026-04 · 20

DOI: 10.1177/26334941261438664 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Therapeutic Advances in Reproductive Health, online erschienen am 05.04.2026. Verfasst von Tammy H Tran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, 700 HMC Crescent Road, Hershey, PA 17033, USA. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder characterized by inattentiveness, hyperactivity, and impulsivity, often treated with amphetamine and methylphenidate agents. There is limited published data to provide established guidelines for stimulant use during pregnancy, and even less data on particular medications. This case study reports maternal–fetal outcomes with lisdexamfetamine (Vyvanse) use during pregnancy and breastfeeding. The patient who received this medication during her second pregnancy experienced significant improvement in her mental well-being compared to her first pregnancy, despite a similar pregnancy course and fetal outcomes, including preterm delivery, neonatal intensive care unit admission, cleft palate, and micrognathia in both pregnancies. In addition, this case demonstrates one instance of successful breastfeeding with maternal use of lisdexamfetamine with no observed side effects in the infant. This report highlights the importance of managing ADHD during pregnancy and the postpartum period and offers an example of breastfeeding without significant side effects or concerns.

Schlagwörter

Stichwörter der Autor:innen

attention-deficit/hyperactivity disorderclinical pharmacologyperinatal stimulant usereproductive psychopharmacology

Autor:innen und Institutionen

  • Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, 700 HMC Crescent Road, Hershey, PA 17033, USA.
  • Department of Psychiatry and Behavioral Health, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.

ORCID-Profile: Tammy H Tran, Marissa L Beal, Ritika Baweja

Zitieren

APA

Tran, T. H., Beal, M. L., Free, M. F., & Baweja, R. (2026). To use or not use lisdexamfetamine in pregnancy and breastfeeding: a case report highlighting ADHD management and maternal–fetal outcomes. Therapeutic Advances in Reproductive Health, 20. https://doi.org/10.1177/26334941261438664

Vancouver

Tran TH, Beal ML, Free MF, Baweja R. To use or not use lisdexamfetamine in pregnancy and breastfeeding: a case report highlighting ADHD management and maternal–fetal outcomes. Therapeutic Advances in Reproductive Health. 2026;20. doi:10.1177/26334941261438664

BibTeX
@article{Tran2026,
  author = {Tran, Tammy H and Beal, Marissa L and Free, Melissa F and Baweja, Ritika},
  title = {To use or not use lisdexamfetamine in pregnancy and breastfeeding: a case report highlighting ADHD management and maternal–fetal outcomes},
  journal = {Therapeutic Advances in Reproductive Health},
  year = {2026},
  volume = {20},
  doi = {10.1177/26334941261438664}
}
Kostenlos starten →